Background illustration for clinical trials search

Paid Clinical Trials Jersey City

Discover 1,567 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,567

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma,

Location: New York NY, Hackensack NJ, The Bronx NY, Allentown PA,

Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT05826535

Phase1, Phase2, Recruiting

A Study of LY4175408 in Participants With Advanced Cancer

for

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma,

Location: New York NY, Hackensack NJ, Boston MA, Fairfax VA,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07046923

Phase1, Recruiting

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

for

Mesothelioma, Non Small Cell Lung Cancer,

Location: New York NY, Mineola NY, New Brunswick NJ,

Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05245500

Phase1, Recruiting

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

for

Solid Tumor, Adult

Location: New York NY, Middletown NJ, Harrison NY, Commack NY,

Sponsor: Effector Therapeutics

Sex: All

Age: 18+

Code: NCT04092673

Phase1, Phase2, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for

Heart Failure

Location: Brooklyn NY, New York NY, Queens Village NY,

Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

for

Macular Edema Secondary to Inflammation

Location: New York NY, Palisades Park NJ, Greenwich CT,

Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06990399

Phase3, Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

for

Macular Edema Secondary to Inflammation

Location: New York NY, Palisades Park NJ, Greenwich CT,

Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT06996080

Phase3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for

Acute Coronary Syndrome

Location: Staten Island NY, New York NY, Hackensack NJ,

Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

for

Esophageal Squamous Cell Carcinoma

Location: Brooklyn NY, Morristown NJ, Hershey PA, Fairfax VA,

Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06644781

Phase3, Recruiting

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

for

Sickle Cell Disease

Location: Brooklyn NY, Newark NJ, The Bronx NY, Queens NY,

Sponsor: Novo Nordisk A/S

Sex: All

Age: 12+

Code: NCT06612268

Phase3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for

Breast Neoplasms

Location: New York NY, The Bronx NY, Florham Park NJ,

Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase3, Recruiting

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

for

Type II Diabetes Mellitus

Location: Brooklyn NY, Berlin NJ, Springfield MA,

Sponsor: Corxel Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07340320

Phase2, Recruiting

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

for

Rhinovirus Infection

Location: Brooklyn NY, Hamilton NJ, Binghamton NY, Sayre PA,

Sponsor: Altesa Biosciences, Inc.

Sex: All

Age: 40 - 70+

Code: NCT07610395

Phase2, Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for

Cardiovascular Disease

Location: Brooklyn NY, New York NY, The Bronx NY, Laurelton NY,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase3, Recruiting

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

for

Major Depressive Disorder

Location: New York NY, Brooklyn NY, Toms River NJ,

Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18 - 65

Code: NCT05850689

Phase3, Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for

Overweight, Obesity

Location: Long Island City NY, Warren Township NJ, Eatontown NJ,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase3, Recruiting

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

for

HER2-positive Gastric Cancer,

Location: New York NY, Summit NJ, Silver Spring MD, Fairfax VA,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06764875

Phase3, Recruiting

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

for

Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma,

Location: New York NY, Hackensack NJ, New Brunswick NJ,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06564038

Phase1, Phase2, Recruiting

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

for

B-cell Malignancies

Location: New York NY, Hackensack NJ, Montreal, Toronto,

Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06542250

Phase1, Phase2, Recruiting

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

for

Transthyretin Amyloidosis, ATTR-CM, ATTRv-PN, ATTR, ATTR-Mixed,

Location: New York NY, Manhasset NY, New Brunswick NJ,

Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06465810

Recruiting

Paid Clinical Trials Jersey City

Filter results

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

A Study of LY4175408 in Participants With Advanced Cancer

Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Interested in new trials?

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis